-
A point-prevalence study on community and inpatient Clostridioides difficile infections (CDI) : results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018Healthcare Associated Infections Research Group. Leeds Institute of Medical Research. University of LeedsBackgroundThere is a paucity of data on community-based Clostridioides difficile infection (CDI) and how these compare with inpatient CDI.AimTo compare data on the populations with CDI in hospitals ... vs the community across 12 European countries.MethodsFor this point-prevalence study (July-November 2018), testing sites sent residual diagnostic material on sampling days to a coordinating laboratory for CDI testing and PCR ribotyping (n = 3,163). Information on whether CDI testing was requested at the original site was used to identify undiagnosed CDI. We used medical records to identify differences between healthcare settings in patient demographics and risk factors for detection of C. difficile with or without free toxin.ResultsThe CDI positivity rate was 4.4% (country range: 0-16.2) in hospital samples, and 1.3% (country range: 0-2.2%) in community samples. The highest prevalence of toxinotype IIIb (027, 181 and 176) was seen in eastern European countries (56%; 43/77), the region with the lowest testing rate (58%; 164/281). Different predisposing risk factors were observed (use of broad-spectrum penicillins in the community (OR: 8.09 (1.9-35.6), p = 0.01); fluoroquinolones/cephalosporins in hospitals (OR: 2.2 (1.2-4.3), p = 0.01; OR: 2.0 (1.1-3.7), p = 0.02)). Half of community CDI cases were undetected because of absence of clinical suspicion, accounting for three times more undiagnosed adults in the community compared with hospitals (ca 111,000 vs 37,000 cases/year in Europe).ConclusionThese findings support recommendations for improving diagnosis in patients presenting with diarrhoea in the community, to guide good practice to limit the spread of CDI.Vir: Eurosurveillance : European communicable disease quartely. - ISSN 1025-496X (Vol. 27, iss 26, Jun. 2022, str. 1-13)Vrsta gradiva - članek, sestavni del ; neleposlovje za odrasleLeto - 2022Jezik - angleškiCOBISS.SI-ID - 120466179
Avtor
Viprey, Virginie F |
Davis, Georgina L |
Benson, Anthony D |
Ewin, Duncan |
Spittal, William |
Vernon, Jon J |
Rupnik, Maja, 1967- |
Healthcare Associated Infections Research Group |
Leeds Institute of Medical Research |
University of Leeds
Drugi avtorji
Wilcox, Mark, mikrobiolog |
Davies, Kerrie A
Teme
clostridioides difficile |
community |
diagnosis |
hospital |
hospital
![loading ... loading ...](themes/default/img/ajax-loading.gif)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Viprey, Virginie F | ![]() |
Davis, Georgina L | ![]() |
Benson, Anthony D | ![]() |
Ewin, Duncan | ![]() |
Spittal, William | ![]() |
Vernon, Jon J | ![]() |
Rupnik, Maja, 1967- | 12278 |
Wilcox, Mark, mikrobiolog | ![]() |
Davies, Kerrie A | ![]() |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.